Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes.

Glia
Jens O WatzlawikM Rodriguez

Abstract

Human remyelination promoting IgM mAbs target oligodendrocytes (OLs) and function in animal models of multiple sclerosis (MS). However, their mechanism of action is unknown. This study seeks to identify the cellular mechanism of action of a recombinant human IgM on OL survival. Binding of rHIgM22 to the surface of rat OLs was studied by co-localization with various markers. RHIgM22-mediated effects on apoptotic signaling in OLs, differentiation markers, and signaling molecules were detected by Western blotting and immunoprecipitation. RHIgM22 co-localized with integrin β3 but not other integrin β-chains in OLs. Downstream of integrin β3 we identified Src family kinase (SFK) Lyn as a key player of rHIgM22-mediated actions in OLs. Lyn immunoprecipitated in a complex together with integrin αvβ3 and PDGFαR. Lyn expression was 9-fold up-regulated and Lyn activation was 3-fold higher inrHIgM22-treated OL cultures compared with controls. RHIgM22 inhibited apoptotic signaling by greater than 10-fold reduction of caspase-3 and capsase-9 cleavage and reduced by 4-fold expression of differentiation markers MBP and MOG in OLs. SFK inhibitors PP2 and SU6656 inhibited Lyn activity and restored caspase-cleavage in OLs. A human IgM that did no...Continue Reading

References

Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·O BöglerM Noble
Jun 1, 1980·The Journal of Cell Biology·K D McCarthy, J de Vellis
Aug 15, 1997·The Biochemical Journal·G M Cohen
Oct 3, 1999·Physiological Reviews·C H Heldin, B Westermark
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·A E WarringtonM Rodriguez
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker
Nov 14, 2000·Molecular and Cellular Biology·R A BlakeS A Courtneidge
Aug 23, 2001·Proceedings of the National Academy of Sciences of the United States of America·A V GrishinS J Corey
Feb 22, 2002·European Journal of Biochemistry·Yukihito KabuyamaYoshimi Homma
Apr 17, 2002·Lancet·Alastair Compston, Alasdair Coles
Oct 16, 2002·Nature Cell Biology·Holly ColognatoCharles ffrench-Constant
Jan 22, 2003·The Biochemical Journal·Jenny BainPhilip Cohen
Jan 28, 2003·Current Biology : CB·Wia BaronCharles ffrench-Constant
Apr 3, 2003·Biochemical and Biophysical Research Communications·Jianguo GuKiyotoshi Sekiguchi
Jan 31, 2004·Neurobiology of Disease·Charles L HoweMoses Rodriguez
Apr 16, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Laurence Decker, Charles ffrench-Constant
May 26, 2004·Biochemical Society Transactions·L DeckerC Ffrench-Constant
Jun 23, 2004·Oncogene·Seok Soon ParkKyeong Sook Choi
Oct 27, 2004·The Journal of Cell Biology·Holly ColognatoCharles ffrench-Constant
Jan 15, 2005·The Journal of Clinical Investigation·Antonella ContriArianna Donella-Deana
Sep 17, 2005·Cancer Research·Deepak K SharmaRichard E Pagano
Jul 21, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yves BenningerJoão B Relvas
Feb 17, 2007·Journal of Neuroscience Research·Arthur E WarringtonMoses Rodriguez
Apr 27, 2007·Journal of the Neurological Sciences·W F Blakemore
Sep 14, 2007·The Biochemical Journal·Jenny BainPhilip Cohen
Aug 7, 2008·The Journal of Biological Chemistry·Daria A ChudakovaTatyana I Gudz
Oct 22, 2008·Nature Reviews. Neuroscience·Robin J M Franklin, Charles Ffrench-Constant

❮ Previous
Next ❯

Citations

Nov 19, 2013·Drugs·E Jolanda MünzelAnna Williams
Mar 30, 2011·Nature Chemical Biology·Stuart M CahalanHugh Rosen
Apr 8, 2011·Nature Reviews. Cancer·Patricia S SteegQuentin R Smith
Oct 30, 2010·Nature Reviews. Drug Discovery·Volker BrinkmannPascale Burtin
Feb 12, 2014·Reproduction : the Official Journal of the Society for the Study of Fertility·Anubha JoshiRajesh Kumar Jha
Jun 6, 2012·Autoimmune Diseases·Bharath WootlaMoses Rodriguez
Oct 1, 2011·Neurology Research International·Bharath WootlaMoses Rodriguez
Jun 5, 2013·Expert Review of Clinical Immunology·Bharath WootlaMoses Rodriguez
Mar 28, 2012·Expert Review of Neurotherapeutics·Bharath WootlaMoses Rodriguez
May 23, 2012·Expert Opinion on Investigational Drugs·Tadeusz Robak, Ewa Robak
Jan 23, 2016·Brain, Behavior, and Immunity·Anthony Fernandez-Castaneda, Alban Gaultier
Feb 26, 2016·Expert Opinion on Biological Therapy·Bharath WootlaMoses Rodriguez
Jul 25, 2013·Scientific Reports·Xiaohua XuMoses Rodriguez
Aug 10, 2011·Journal of Neurochemistry·Xiaohua XuMoses Rodriguez
Aug 13, 2011·Developmental Neurobiology·Holly Colognato, Iva D Tzvetanova
Feb 14, 2015·Biochimica Et Biophysica Acta·Massimo AureliAlessandro Prinetti
Feb 26, 2015·Neurodegenerative Disease Management·Anna Williams
Feb 14, 2015·Future Neurology·Xiaohua XuMoses Rodriguez
Sep 28, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Riley M Bove, Ari J Green
Nov 1, 2013·Clinical Pharmacology and Therapeutics·O H KantarciM Rodriguez
Apr 30, 2020·Expert Opinion on Investigational Drugs·Stefan Gingele, Martin Stangel
Jan 21, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Srini V KaveriJagadeesh Bayry
Nov 20, 2016·Annual Review of Medicine·Mark Bothwell
Aug 21, 2019·Frontiers in Pharmacology·Sara GrassiPaola Giussani
Nov 21, 2021·Clinical and Translational Science·Kawita M S KanhaiGeert Jan Groeneveld

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.